SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

Hodgkin lymphoma (HL) is an uncommon B cell lymphoid malignancy representing approximately 10–15 % of all lymphomas. HL is composed of two distinct disease entities; the more commonly diagnosed classical HL and the rare nodular lymphocyte-predominant HL. An accurate assessment of the stage of disea...

Full description

Bibliographic Details
Main Authors: Rueda Domínguez, A., Alfaro Lizaso, J., de la Cruz Merino, L., Gumá i Padró, J., Quero Blanco, C., Gómez Codina, J., Llanos Muñoz, M., Martinez Banaclocha, N., Rodriguez Abreu, D., Provencio Pulla, M.
Format: Online
Language:English
Published: Springer Milan 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689754/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689754/

Similar Items